南新制药：累计回购公司股份357179股

Core Viewpoint - Company announced a share buyback program, indicating confidence in its financial health and future prospects [2] Group 1 - As of October 31, 2025, the company has repurchased a total of 357,179 shares [2] - The repurchased shares represent 0.13% of the company's total share capital of 274,400,000 shares [2]